Hehakaya C, Moors E
Innovation (North Syd). 2025; 27(1):74-95.
PMID: 39935856
PMC: 11809769.
DOI: 10.1080/14479338.2023.2213212.
Konrad M, Brink C, Bertelsen A, Lorenzen E, Celik B, Nyborg C
Phys Imaging Radiat Oncol. 2025; 33:100694.
PMID: 39885904
PMC: 11780162.
DOI: 10.1016/j.phro.2024.100694.
Allegra A, Nicosia L, Rigo M, Bianchi N, Borgese R, Simone A
Technol Cancer Res Treat. 2025; 24:15330338241297231.
PMID: 39865869
PMC: 11770696.
DOI: 10.1177/15330338241297231.
Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N
Phys Imaging Radiat Oncol. 2024; 32():100678.
PMID: 39717186
PMC: 11665667.
DOI: 10.1016/j.phro.2024.100678.
Wang H, Li Z, Shi D, Yin P, Liang B, Zou J
Radiat Oncol. 2024; 19(1):176.
PMID: 39696365
PMC: 11653819.
DOI: 10.1186/s13014-024-02569-5.
Upper Urinary Tract Stereotactic Body Radiotherapy Using a 1.5 Tesla Magnetic Resonance Imaging-Guided Linear Accelerator: Workflow and Physics Considerations.
Zhao Y, Cozma A, Ding Y, Perles L, Reiazi R, Chen X
Cancers (Basel). 2024; 16(23).
PMID: 39682173
PMC: 11640540.
DOI: 10.3390/cancers16233987.
3D gel dosimeter assessment for end-to-end geometric accuracy determination of the online adaptive workflow on the 1.5 T MR-linac.
Oolbekkink S, Wolthaus J, van Asselen B, Raaymakers B
Phys Imaging Radiat Oncol. 2024; 32:100664.
PMID: 39583957
PMC: 11585670.
DOI: 10.1016/j.phro.2024.100664.
The Role of CT and MR Imaging in Stereotactic Body Radiotherapy of the Spine: From Patient Selection and Treatment Planning to Post-Treatment Monitoring.
Azadbakht J, Condos A, Haynor D, Gibbs W, Jabehdar Maralani P, Sahgal A
Cancers (Basel). 2024; 16(21).
PMID: 39518130
PMC: 11545634.
DOI: 10.3390/cancers16213692.
Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac.
Liu M, Liu M, Yang F, Liu Y, Wang S, Chen Y
Radiat Oncol. 2024; 19(1):144.
PMID: 39402595
PMC: 11475857.
DOI: 10.1186/s13014-024-02533-3.
Magnetic Resonance-Guided Cancer Therapy Radiomics and Machine Learning Models for Response Prediction.
Fajemisin J, Gonzalez G, Rosenberg S, Ullah G, Redler G, Latifi K
Tomography. 2024; 10(9):1439-1454.
PMID: 39330753
PMC: 11435563.
DOI: 10.3390/tomography10090107.
Evaluating the effect of higher Monte Carlo statistical uncertainties on accumulated doses after daily adaptive fractionated radiotherapy in prostate cancer.
Jagt T, Janssen T, Sonke J
Phys Imaging Radiat Oncol. 2024; 32:100636.
PMID: 39295957
PMC: 11405816.
DOI: 10.1016/j.phro.2024.100636.
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review.
Ristau J, Horner-Rieber J, Korber S
J Gastrointest Oncol. 2024; 15(4):1893-1907.
PMID: 39279945
PMC: 11399841.
DOI: 10.21037/jgo-22-961.
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.
van Goor I, Andel P, Buijs F, Besselink M, Bonsing B, Bosscha K
Ann Surg Oncol. 2024; 31(12):8264-8275.
PMID: 38937412
PMC: 11467030.
DOI: 10.1245/s10434-024-15664-4.
A systematic literature review: deep learning techniques for synthetic medical image generation and their applications in radiotherapy.
Sherwani M, Gopalakrishnan S
Front Radiol. 2024; 4:1385742.
PMID: 38601888
PMC: 11004271.
DOI: 10.3389/fradi.2024.1385742.
MR signature matching (MRSIGMA) implementation for true real-time free-breathing volumetric imaging with sub-200 ms latency on an MR-Linac.
Siddiq S, Murray V, Tyagi N, Borman P, Gui C, Crane C
Magn Reson Med. 2024; 92(3):1162-1176.
PMID: 38576131
PMC: 11209806.
DOI: 10.1002/mrm.30097.
Three-row MRI receive array with remote circuitry to preserve radiation transparency.
Lakshmanan K, Wang B, Walczyk J, Collins C, Brown R
Phys Med Biol. 2024; 69(9).
PMID: 38537307
PMC: 11071057.
DOI: 10.1088/1361-6560/ad388c.
Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study.
Daamen L, Westerhoff J, Couwenberg A, Braam P, Rutten H, den Hartogh M
Clin Transl Radiat Oncol. 2024; 45:100721.
PMID: 38274389
PMC: 10808928.
DOI: 10.1016/j.ctro.2023.100721.
MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
Ocanto A, Torres L, Montijano M, Rincon D, Fernandez C, Sevilla B
Cancers (Basel). 2024; 16(2).
PMID: 38254760
PMC: 10813892.
DOI: 10.3390/cancers16020270.
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac.
de Mol van Otterloo S, Westerhoff J, Leer T, Rutgers R, Meijers L, Daamen L
Tech Innov Patient Support Radiat Oncol. 2024; 29:100224.
PMID: 38162695
PMC: 10755768.
DOI: 10.1016/j.tipsro.2023.100224.
Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
Rusu D, Cunningham J, Arch J, Chetty I, Parikh P, Dolan J
Front Oncol. 2024; 13:1298099.
PMID: 38162503
PMC: 10756668.
DOI: 10.3389/fonc.2023.1298099.